Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma

Biochemical and Biophysical Research Communications

Volumn 342, Issue 4, 2006, Pages 1228-1232

  Batra, Sonny ^a   Shi, Yihui ^a   Kuchenbecker, Kristopher M ^a   He, Biao ^a   Reguart, Noemi ^a,b   Mikami, Iwao ^a   You, Liang ^a   Xu, Zhidong ^a   Lin, Yu Ching ^a   Clément, Geneviève ^a   Jablons, David M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Promoter hypermethylation; Wnt inhibitory factor 1; Wnt signaling

Indexed keywords

UNCLASSIFIED DRUG; WNT ANTAGONIST; WNT INHIBITORY FACTOR 1; WNT PROTEIN;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MESOTHELIUM CELL; METHYLATION; PLEURA; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

CARRIER PROTEINS; CELL LINE, TUMOR; DNA METHYLATION; GENE SILENCING; HUMANS; MESOTHELIOMA; PLEURAL NEOPLASMS; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 33644912283     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.02.084     Document Type: Article

References (48)

1. N. Thatcher Second Heidelberg thoracic oncology symposium on the diagnosis and treatment of pleural mesothelioma-introduction Lung Cancer 45 Suppl. 1 2004 S1 S2
2. J.E. Herndon, M.R. Green, A.P. Chahinian, J.M. Corson, Y. Suzuki, and N.J. Vogelzang Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the cancer and leukemia group B Chest 113 1998 723 731
3. R. Bueno Mesothelioma clinical presentation Chest 116 1999 444S 445S
4. R. Nusse, and H.E. Varmus Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome Cell 31 1982 99 109
5. P. Polakis Wnt signaling and cancer Genes Dev. 14 2000 1837 1851
6. P.J. Morin, A.B. Sparks, V. Korinek, N. Barker, H. Clevers, B. Vogelstein, and K.W. Kinzler Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC Science 275 1997 1787 1790
7. A.T. Weeraratna, Y. Jiang, G. Hostetter, K. Rosenblatt, P. Duray, M. Bittner, and J.M. Trent Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma Cancer Cell 1 2002 279 288
8. K. Uematsu, B. He, L. You, Z. Xu, F. McCormick, and D.M. Jablons Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression Oncogene 22 2003 7218 7221
9. D. Lu, Y. Zhao, R. Tawatao, H.B. Cottam, M. Sen, L.M. Leoni, T.J. Kipps, M. Corr, and D.A. Carson Activation of the Wnt signaling pathway in chronic lymphocytic leukemia Proc. Natl. Acad. Sci. USA 101 2004 3118 3123
10. K. Uematsu, S. Kanazawa, L. You, B. He, Z. Xu, K. Li, B.M. Peterlin, F. McCormick, and D.M. Jablons Wnt pathway activation in mesothelioma: evidence of dishevelled overexpression and transcriptional activity of beta-catenin Cancer Res. 63 2003 4547 4551
11. C. Liu, Y. Li, M. Semenov, C. Han, G.H. Baeg, Y. Tan, Z. Zhang, X. Lin, and X. He Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism Cell 108 2002 837 847
12. S. Ikeda, S. Kishida, H. Yamamoto, H. Murai, S. Koyama, and A. Kikuchi Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin EMBO J. 17 1998 1371 1384
13. B. Rubinfeld, I. Albert, E. Porfiri, C. Fiol, S. Munemitsu, and P. Polakis Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly Science 272 1996 1023 1026
14. S. Amit, A. Hatzubai, Y. Birman, J.S. Andersen, E. Ben-Shushan, M. Mann, Y. Ben-Neriah, and I. Alkalay Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway Genes Dev. 16 2002 1066 1076
15. M. Hart, J.P. Concordet, I. Lassot, I. Albert, R. del los Santos, H. Durand, C. Perret, B. Rubinfeld, F. Margottin, R. Benarous, and P. Polakis The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell Curr. Biol. 9 1999 207 210
16. M. Kitagawa, S. Hatakeyama, M. Shirane, M. Matsumoto, N. Ishida, K. Hattori, I. Nakamichi, A. Kikuchi, K. Nakayama, and K. Nakayama An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin EMBO J. 18 1999 2401 2410
17. J.T. Winston, P. Strack, P. Beer-Romero, C.Y. Chu, S.J. Elledge, and J.W. Harper The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro Genes Dev. 13 1999 270 283
18. K. Itoh, V.E. Krupnik, and S.Y. Sokol Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and beta-catenin Curr. Biol. 8 1998 591 594
19. S. Kishida, H. Yamamoto, S. Hino, S. Ikeda, M. Kishida, and A. Kikuchi DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability Mol. Cell. Biol. 19 1999 4414 4422
20. J.S. Lee, A. Ishimoto, and S. Yanagawa Characterization of mouse dishevelled (Dvl) proteins in Wnt/Wingless signaling pathway J. Biol. Chem. 274 1999 21464 21470
21. J. Behrens, J.P. von Kries, M. Kuhl, L. Bruhn, D. Wedlich, R. Grosschedl, and W. Birchmeier Functional interaction of beta-catenin with the transcription factor LEF-1 Nature 382 1996 638 642
22. J. Behrens, and B. Lustig The Wnt connection to tumorigenesis Int. J. Dev. Biol. 48 2004 477 487
23. M. Shtutman, J. Zhurinsky, I. Simcha, C. Albanese, M. D'Amico, R. Pestell, and A. Ben-Ze'ev The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway Proc. Natl. Acad. Sci. USA 96 1999 5522 5527
24. T. Zhang, T. Otevrel, Z. Gao, S.M. Ehrlich, J.Z. Fields, and B.M. Boman Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer Cancer Res. 61 2001 8664 8667
25. X. Zhang, J.P. Gaspard, and D.C. Chung Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia Cancer Res. 61 2001 6050 6054
26. M.T. Veeman, J.D. Axelrod, and R.T. Moon A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling Dev. Cell 5 2003 367 377
27. P. Fedi, A. Bafico, A. Nieto Soria, W.H. Burgess, T. Miki, D.P. Bottaro, M.H. Kraus, and S.A. Aaronson Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling J. Biol. Chem. 274 1999 19465 19472
28. Y. Kawano, and R. Kypta Secreted antagonists of the Wnt signalling pathway J. Cell Sci. 116 2003 2627 2634
29. J.C. Hsieh, L. Kodjabachian, M.L. Rebbert, A. Rattner, P.M. Smallwood, C.H. Samos, R. Nusse, I.B. Dawid, and J. Nathans A new secreted protein that binds to Wnt proteins and inhibits their activities Nature 398 1999 431 436
30. K. Lin, S. Wang, M.A. Julius, J. Kitajewski, M. Moos Jr., and F.P. Luyten The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling Proc. Natl. Acad. Sci. USA 94 1997 11196 11200
31. C. Wissmann, P.J. Wild, S. Kaiser, S. Roepcke, R. Stoehr, M. Woenckhaus, G. Kristiansen, J.C. Hsieh, F. Hofstaedter, A. Hartmann, R. Knuechel, A. Rosenthal, and C. Pilarsky WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer J. Pathol. 201 2003 204 212
32. J. Mazieres, B. He, L. You, Z. Xu, A.Y. Lee, I. Mikami, N. Reguart, R. Rosell, F. McCormick, and D.M. Jablons Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer Cancer Res. 64 2004 4717 4720
33. H. Taniguchi, H. Yamamoto, T. Hirata, N. Miyamoto, M. Oki, K. Nosho, Y. Adachi, T. Endo, K. Imai, and Y. Shinomura Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers Oncogene 24 2005 7946 7952
34. C. Haqq, M. Nosrati, D. Sudilovsky, J. Crothers, D. Khodabakhsh, B.L. Pulliam, S. Federman, J.R. Miller 3rd, R.E. Allen, M.I. Singer, S.P. Leong, B.M. Ljung, R.W. Sagebiel, and M. Kashani-Sabet The gene expression signatures of melanoma progression Proc. Natl. Acad. Sci. USA 102 2005 6092 6097
35. Y.C. Lin, L. You, Z. Xu, B. He, I. Mikami, E. Thung, J. Chou, K. Kuchenbecker, J. Kim, D. Raz, C.T. Yang, J.K. Chen, and D.M. Jablons Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines Biochem. Biophys. Res. Commun. 341 2006 635 640
36. S.Y. Shu, and S.A. Rosenberg Adoptive immunotherapy of newly induced murine sarcomas Cancer Res. 45 1985 1657 1662
37. J.F. Lechner, T. Tokiwa, M. LaVeck, W.F. Benedict, S. Banks-Schlegel, H. Yeager Jr., A. Banerjee, and C.C. Harris Asbestos-associated chromosomal changes in human mesothelial cells Proc. Natl. Acad. Sci. USA 82 1985 3884 3888
38. N. Reguart, B. He, Z. Xu, L. You, A.Y. Lee, J. Mazieres, I. Mikami, S. Batra, R. Rosell, F. McCormick, and D.M. Jablons Cloning and characterization of the promoter of human Wnt inhibitory factor-1 Biochem. Biophys. Res. Commun. 323 2004 229 234
39. B. He, L. You, K. Uematsu, Z. Xu, A.Y. Lee, M. Matsangou, F. McCormick, and D.M. Jablons A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells Neoplasia 6 2004 7 14
40. A.Y. Lee, B. He, L. You, S. Dadfarmay, Z. Xu, J. Mazieres, I. Mikami, F. McCormick, and D.M. Jablons Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma Oncogene 23 2004 6672 6676
41. F. Ugolini, E. Charafe-Jauffret, V.J. Bardou, J. Geneix, J. Adelaide, F. Labat-Moleur, F. Penault-Llorca, M. Longy, J. Jacquemier, D. Birnbaum, and M.J. Pebusque WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type Oncogene 20 2001 5810 5817
42. J. Ko, K.S. Ryu, Y.H. Lee, D.S. Na, Y.S. Kim, Y.M. Oh, I.S. Kim, and J.W. Kim Human secreted frizzled-related protein is down-regulated and induces apoptosis in human cervical cancer Exp. Cell Res. 280 2002 280 287
43. G.M. Caldwell, C. Jones, K. Gensberg, S. Jan, R.G. Hardy, P. Byrd, S. Chughtai, Y. Wallis, G.M. Matthews, and D.G. Morton The Wnt antagonist sFRP1 in colorectal tumorigenesis Cancer Res. 64 2004 883 888
44. K.F. To, M.W. Chan, W.K. Leung, J. Yu, J.H. Tong, T.L. Lee, F.K. Chan, and J.J. Sung Alterations of frizzled (FzE3) and secreted frizzled related protein (hsFRP) expression in gastric cancer Life Sci. 70 2001 483 489
45. H. Suzuki, D.N. Watkins, K.W. Jair, K.E. Schuebel, S.D. Markowitz, W.D. Chen, T.P. Pretlow, B. Yang, Y. Akiyama, M. Van Engeland, M. Toyota, T. Tokino, Y. Hinoda, K. Imai, J.G. Herman, and S.B. Baylin Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer Nat. Genet. 36 2004 417 422
46. D.D. Hunter, M. Zhang, J.W. Ferguson, M. Koch, and W.J. Brunken The extracellular matrix component WIF-1 is expressed during, and can modulate, retinal development Mol. Cell. Neurosci. 27 2004 477 488
47. L. Patthy The WIF module Trends Biochem. Sci. 25 2000 12 13
48. T. Ohigashi, R. Mizuno, J. Nakashima, K. Marumo, and M. Murai Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells Prostate 62 2005 61 68